ConocoPhillips vs HCA Health Inc — how do they compare? ConocoPhillips trades at $134.7 (market cap $161.21B), while HCA Health Inc trades at $446.39 (market cap $96.35B). The key difference: ConocoPhillips is the larger of the two by market cap, and ConocoPhillips pays the higher dividend (2.5%). Which is the better fit depends on your goals — on Pluang, investors hold ConocoPhillips for 79 Days and HCA Health Inc for 76 Days on average.
| COP | HCA | |
|---|---|---|
Market Cap | $161.21B | $96.35B |
Volume | 6,058,403 | 1,079,453 |
Sector | Energy | Health |
52-Week High | $141.22 | $545.13 |
52-Week Low | $85.66 | $361.32 |
Typical Hold Time | 79 Days | 76 Days |
Enterprise Value | $176.81B | $146.88B |
Dividend Yield | 2.5% | 0.7% |
Signals from Pluang's Aura AI — not financial advice
ConocoPhillips (COP) trades at $134.52, up 3.6% with strong technical momentum and bullish analyst sentiment. The stock shows robust fundamentals with Q2 2026 EPS beating expectations at $3.24 versus $2.90, supported by a 20-year LNG supply agreement with Venture Global. Valuation metrics appear reasonable with P/E at 17.75 and EV/EBITDA at 6.36, while profitability remains solid with 14.65% net income margin and 14.14% ROE.
Outlook remains positive with consensus price target of $154.75 representing 15% upside potential. Key risks include oil price volatility and geopolitical exposure in international operations. The company's strong cash flow generation and strategic LNG expansion provide growth catalysts, though investors should monitor execution on asset sales and energy market dynamics.
HCA Healthcare (HCA) trades at $439.17, up 1.61% today, with a bullish technical signal and strong fundamental performance. Revenue grew to $75.6 billion in 2025, with net income reaching $6.78 billion, and the company has beaten EPS estimates for three consecutive quarters. Recent news includes an upcoming Q3 2026 earnings call and the completion of the College of Health Care Professions acquisition, highlighting operational expansion.
The outlook remains positive with a consensus price target of $461.12, though risks include ongoing legal investigations and high debt levels. Earnings growth and cost controls support upside potential, but investors should monitor regulatory developments and payer-mix pressures that could impact margins.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
ConocoPhillips is a U.S.-based independent exploration and production firm. In 2021, it produced 1.0 million barrels per day of oil and natural gas liquids and 3.2 billion cubic feet per day of natural gas, primarily from Alaska and the Lower 48 in the United States and Norway in Europe and several countries in Asia-Pacific and the Middle East. Proven reserves at year-end 2021 were 6.1 billion barrels of oil equivalent.
Read more on COP →HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →